Your Search Results

To rescue the unexpected complications during TAVI

20 May 2026 – From EuroPCR 2026

This session focuses on the recognition and management of unexpected complications during TAVI procedures. Through cases from Hong Kong, Kazakhstan, and Uzbekistan, it examines mechanisms underlying common and rare complications such as aortic sinus injury, acute valve dislocation, and left main collapse. Attendees gain practical insights...

Imaging the calcified lesions: what you need to see

20 May 2026 – From EuroPCR 2026

This session emphasizes critical imaging aspects necessary for assessing calcified coronary lesions. It addresses lesion-specific Agatston scoring, OCT-guided PCI optimization, coronary CT planning, histopathological insights, and predictors of stent underexpansion after calcium modification.

Lessons from the long-term DES data: how they can inform today's practice

20 May 2026 – From EuroPCR 2026

This session reviews long-term clinical data on drug-eluting stents (DES) and bioresorbable scaffolds (BRS), offering valuable insights to inform current interventional cardiology practice. It covers seven-year outcomes of magnesium scaffolds in ACS, five-year results of sirolimus-eluting iron BRS, and extensive post-market studies of various thin-strut and...

Major Late-Breaking Trials from EuroPCR 2026

20 May 2026 – From EuroPCR 2026

This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.